Royal Bank of Canada set a CHF 104 price target on Swiss Re (VTX:SREN) in a research note published on Monday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.
A number of other equities analysts have also recently weighed in on SREN. Credit Suisse Group restated a neutral rating and set a $100.00 price objective on shares of Procter & Gamble in a research report on Tuesday, April 23rd. JPMorgan Chase & Co. set a GBX 3,200 ($41.81) price objective on shares of Diageo and gave the stock a neutral rating in a research report on Wednesday, July 10th. Barclays restated an underweight rating and set a GBX 600 ($7.84) price objective on shares of in a research report on Monday, July 8th. UBS Group upgraded shares of to a neutral rating and upped their price objective for the stock from GBX 945 ($12.35) to GBX 2,060 ($26.92) in a research report on Thursday, June 20th. Finally, Deutsche Bank restated a hold rating and set a GBX 1,775 ($23.19) price objective on shares of in a research report on Wednesday, June 26th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and eight have assigned a buy rating to the company. Swiss Re has a consensus rating of Buy and an average target price of CHF 105.67.
Swiss Re has a 12-month low of CHF 81.65 and a 12-month high of CHF 98.80.
About Swiss Re
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Featured Article: Momentum Indicators
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.